• Nenhum resultado encontrado

[PDF] Top 20 Parkinson’s Disease: Clinical Review and Update

Has 10000 "Parkinson’s Disease: Clinical Review and Update" found on our website. Below are the top 20 most common "Parkinson’s Disease: Clinical Review and Update".

Parkinson’s Disease: Clinical Review and Update

Parkinson’s Disease: Clinical Review and Update

... de Parkinson é a segunda doença neurodegenerativa mais comum, tendo sido documentado um aumento significativo da sua prevalência nas últimas três ...de Parkinson in vivo, à exceção de testes genéti- cos em ... See full document

10

Doença de Parkinson, exercício físico e qualidade de vida: uma revisão / Parkinson's disease, exercise and quality of life: a review

Doença de Parkinson, exercício físico e qualidade de vida: uma revisão / Parkinson's disease, exercise and quality of life: a review

... Parkinson's disease is characterized as a chronic, degenerative and progressive neurological disease that affects the motor ...Parkinson's disease has no cure ...surgeries and adjuvant ... See full document

11

Neuro-Behcet´s disease - case report and review

Neuro-Behcet´s disease - case report and review

... neuro-Behcet’s Disease (NBD) in a young 25-year-old ...speech, and swallowing disorders. Initially, a clinical diagnosis of cerebral in- farction was made, but later the condition was defined as ... See full document

6

Alzheimer's disease: A clinical practice-oriented review

Alzheimer's disease: A clinical practice-oriented review

... tanagnosia, and visual agnosia) and Gerstmann syndrome, with acalculia as the predominant symptom (Galton et ...agraphia and apraxia, and others show occipital dysfunc- tion (involving the ... See full document

20

Sixty hertz neurostimulation amplifies subthalamic neural synchrony in Parkinson's disease.

Sixty hertz neurostimulation amplifies subthalamic neural synchrony in Parkinson's disease.

... gait and speech, but not on tremor ...studies and among ...synchrony, and it is possible that this may contribute to the heterogenic clinical effects of 60 Hz DBS in PD reported so ... See full document

12

Arq. NeuroPsiquiatr.  vol.74 número4

Arq. NeuroPsiquiatr. vol.74 número4

... (Parkinson’s disease, Huntington’s disease, Tourette´s syndrome, spinocerebellar ataxia type 3), were evaluated in the Movement Disorders Unit of the Federal University of ...Parkinson’s ... See full document

4

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

Intra-Rater, Inter-Rater and Test-Retest Reliability of an Instrumented Timed Up and Go (iTUG) Test in Patients with Parkinson's Disease.

... small and light (87×45×14 mm, 74 grams) inertial sensor measurement system (DynaPort Hybrid, McRoberts, The Hague, The Netherlands), which was inserted in an elastic belt and positioned on the lower back ... See full document

11

Arq. NeuroPsiquiatr.  vol.73 número3

Arq. NeuroPsiquiatr. vol.73 número3

... Parkinson’s disease are very ...polysomnography and to determine the associated clinical ...Parkinson’s disease were ...0.049) and body mass index (p = ...0.047) and levodopa ... See full document

5

Congenital Chagas disease: an update

Congenital Chagas disease: an update

... frequent clinical form of Chagas disease) in endemic areas, major differences seem to occur among the different ...(4.1%) and in 115 of 2,691 in Paraguay ...Brazil and other endemic countries ... See full document

6

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

Clinical Characterization of Parkinson s Disease Patients Followed at CHCB Comparison with a control group

... serum and CSF of PD patients when compared with HC,(9) including pro- inflammatory cytokines, like IL-6 (12, 17), IL-12 (19), TNF-, (12, 18) and interferon- (12), and anti-inflammatory cytokines, ... See full document

70

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson's Disease Patients.

... EFTUD2 and PTBP1, correlated with clinical features in early stage drug-naïve PD patients suggesting they may be useful for patient stratifi- cation according to disease severity ...Hoehn and ... See full document

11

Recorrência da infeção por Clostridium difficile: será o transplante fecal uma hipótese a considerar?

Recorrência da infeção por Clostridium difficile: será o transplante fecal uma hipótese a considerar?

... Garg S, Mirza YR, Girotra M, Kumar V, Yoselevitz S, Segon A, et ...difficile-associated disease (CDAD): a shift from hospital-acquired infection to long-term care facility-based ...an update ... See full document

41

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.

Huperzine A for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.

... changes and short treatment duration, which is consistent with the findings of a previous review ...Alzheimer’s disease require lifelong treatment, the long-term safety of the treatment is still an ... See full document

8

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

Diagnostic validity of biomarkers in Parkinson’s Disease: systematic review and meta-analysis

... de Parkinson, el líquido cefalorraquídeo, la sangre, la saliva y la ...el Review Manager ...de Parkinson en su ...de Parkinson; Diagnóstico; Biomarcadores; ... See full document

10

Arq. NeuroPsiquiatr.  vol.70 número6

Arq. NeuroPsiquiatr. vol.70 número6

... acute and chronic diseases characterized by involuntary movements and/or loss of control or ef- ficiency in voluntary ...this review, we covered situations in which the main manifestations are MDs ... See full document

9

Update on Chagas Disease in Venezuela – A Review

Update on Chagas Disease in Venezuela – A Review

... males and 253 ...IgM and IgG levels allowed us to iden- tify ...chronical clinical condition and ...(3.3%) and Trujillo (2.6%)], people in chronic phase and with inapparent ... See full document

7

Parkinson s disease and dopamine transporter neuroimaging: a critical review

Parkinson s disease and dopamine transporter neuroimaging: a critical review

... Parkinsonism-related disease may be associated with a higher degree of nigrostriatal impairment, independent of the clinical severity of the disease, and more symmetrical involvement than in ... See full document

8

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

Imaging Striatal Microglial Activation in Patients with Parkinson's Disease.

... regions and clinical measures has been demonstrated in some studies [8] but not in others ...penetration, and high plasma protein ...wider clinical use due to the short-lived carbon-11 ... See full document

10

Chagas' disease: an update on immune mechanisms and therapeutic strategies

Chagas' disease: an update on immune mechanisms and therapeutic strategies

... response and the parasite in favour of the host [66, ...BZL and NF, differ strongly according to the disease phase, the time extension and the drug dose, as well as the patient’s age ... See full document

12

Coronavirus Disease 2019: Clinical Review

Coronavirus Disease 2019: Clinical Review

... action and effect in humans were indefinite. Intensive research and sharing of clinical experience between healthcare professionals and scientists have been essential to expand the knowledge ... See full document

7

Show all 10000 documents...